POS0431 BASELINE VASCULAR ULTRASOUND OF PMR PATIENTS AT TIME OF DIAGNOSIS STRATIFIES RELAPSE RISK AT 6 MONTHSS. Cowley, David Kane, Richard Conway et al.|Annals of the Rheumatic Diseases|2024Cited by 2
POS0716 DIFFERENCES IN CLINICAL AND ULTRASOUND CHARACTERISTICS OF POLYMYALGIA RHEUMATICA PATIENTS WITH SUBCLINICAL GIANT CELL ARTERITIS COMPARED TO THOSE WITH CLINICAL GIANT CELL ARTERITISS. Cowley, David Kane, Ronan Mullan et al.|Annals of the Rheumatic Diseases|2023Cited by 1
OP0345 PROGNOSTIC VALUE OF QUANTIFYING VASCULAR INFLAMMATION THROUGH ULTRASOUND IN PATIENTS WITH GIANT CELL ARTERITIS: INTERIM ANALYSIS OF THE MAGiCUS STUDYJ. Molina Collada, S. Cowley, Julio Sánchez-Martín et al.|Annals of the Rheumatic Diseases|2025Cited by 1
ABS0911 LONGITUDINAL OUTCOMES UP TO 24 MONTHS IN ISOLATED POLYMYALGIA RHEUMATICAP. Harkins, Richard Conway, David Kane et al.|Annals of the Rheumatic Diseases|2025Cited by 0
POS0754 EVALUATION OF A 28 CYTOKINE PANEL IN STEROID NAIVE PATIENTS WITH ISOLATED PMRP. Harkins, Richard Conway, S. Cowley et al.|Annals of the Rheumatic Diseases|2025Cited by 0